KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardinal Health (CAH) Cash & Equivalents (2016 - 2025)

Cardinal Health (CAH) has disclosed Cash & Equivalents for 17 consecutive years, with $2.8 billion as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents fell 27.11% to $2.8 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.8 billion through Dec 2025, down 27.11% year-over-year, with the annual reading at $3.9 billion for FY2025, 24.53% down from the prior year.
  • Cash & Equivalents hit $2.8 billion in Q4 2025 for Cardinal Health, down from $4.6 billion in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $5.1 billion in Q2 2024 to a low of $2.4 billion in Q1 2022.
  • Historically, Cash & Equivalents has averaged $3.7 billion across 5 years, with a median of $3.7 billion in 2022.
  • Biggest five-year swings in Cash & Equivalents: plummeted 32.67% in 2022 and later surged 69.35% in 2023.
  • Year by year, Cash & Equivalents stood at $3.2 billion in 2021, then grew by 15.6% to $3.7 billion in 2022, then increased by 25.64% to $4.6 billion in 2023, then dropped by 17.01% to $3.8 billion in 2024, then fell by 27.11% to $2.8 billion in 2025.
  • Business Quant data shows Cash & Equivalents for CAH at $2.8 billion in Q4 2025, $4.6 billion in Q3 2025, and $3.9 billion in Q2 2025.